You are here

PBMs

PBM trade group ad campaign hits back at drugmakers over prescription drug prices

Medical Marketing and Media

Wed, 02/22/23 - 06:53 pm

Senate begins quest to demystify PBMs' practices as it mulls legislation

Endpoints

Thu, 02/16/23 - 08:11 pm

Years after the first US biosim launches, doctors still have their concerns: survey

Fierce Pharma

Thu, 02/16/23 - 04:49 pm

Novartis CEO, as incoming PhRMA chair, outlines 3 priorities for pharma after IRA setback

Fierce Pharma

Wed, 02/1/23 - 10:22 pm

Inflation Reduction Act

small molecule drugs

PBMs likely to be a focus in 118th Congress

Roll Call

Fri, 01/27/23 - 10:54 am

The Big Three PBMs’ 2023 Formulary Exclusions: Observations on Insulin, Humira, and Biosimilars

Drug Channels

Tue, 01/10/23 - 10:44 am

Express Scripts

Mark Cuban’s drug company teams with first PBM

Medical Marketing and Media

Wed, 09/28/22 - 11:42 am

Mark Cuban Cost Plus Drugs

Patient groups sue feds to crack down on insurer, PBM copay adjustment programs

Fierce Healthcare

Wed, 08/31/22 - 10:37 am

copay asssistance programs

FTC Unanimously Agrees to Keep Close Eye on PBMs, Higher Drug Costs

BioSpace

Mon, 06/20/22 - 10:27 am

FTC targets insulin, threatening to go after PBM-pharma deals that steer into 'commercial bribery'

Endpoints

Fri, 06/17/22 - 10:04 am

FTC launches probe into pharmacy benefit management sector

Pharmaforum

Wed, 06/8/22 - 10:11 am

Pile-on over PBMs continues with FTC comments and a new bipartisan Senate bill

Endpoints

Thu, 05/26/22 - 10:48 pm

Eli Lilly, Novo Nordisk and Sanofi face new lawsuit from Arkansas AG over insulin prices

Fierce Pharma

Thu, 05/12/22 - 10:54 pm

PBMs in the Senate hot seat as bipartisan transparency measures may take root

Endpoints

Thu, 05/5/22 - 11:25 pm

Community welcomes President Biden’s call to action to rein in high drug prices

MedCity News

Mon, 04/25/22 - 10:14 am

40% of CVS Caremark's PBM clients have a negative specialty drug trend

Beckers Hospital Review

Fri, 02/25/22 - 10:17 am

specialty drugs

When the $10K brand name drug is more affordable than its $450 generic: How PBMs control the system

Endpoints

Sun, 02/20/22 - 11:52 am

FTC deadlocks on vote to launch study into PBM practices

BioPharma Dive

Fri, 02/18/22 - 10:33 am

FTC plots a look into the competitive impact of PBMs on drug prices, pharmacies

Endpoints

Wed, 02/16/22 - 11:16 pm

PBMs ranked by market share: CVS Caremark is No. 1

Beckers Hospital Review

Wed, 02/9/22 - 10:02 am

Express Scripts

Pages